KEI Comment to NIST on Bayh-Dole Rights and Cases of Mixed Patent Landscapes

KEI submitted comments to the National Institute of Standards and Technology (NIST) in response to the Request for Information regarding the “Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights” (88 FR 85593) concerning Bayh-Dole rights and the… Continue Reading

KEI Comment to NIST on Transparency of March-in Proceedings

On December 8, 2023, the National Institute of Standards and Technology (NIST) issued a Request for Information regarding the “Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights” (88 FR 85593). Today KEI submitted comments to NIST regarding… Continue Reading

KEI Comments on the Implications of Access and Benefit Sharing Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement

On January 29, 2024, KEI submitted comments in response the Federal Register notice posted by the Department of Health and Human Services (HHS) concerning, “the Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments Being Considered Under… Continue Reading

EB 154: KEI statement on WHO’s work in health emergencies

On 25 January 2024, Knowledge Ecology International (KEI) delivered this statement on WHO’s work in health emergencies. There is an ongoing need to make investments in countermeasures to tackle possible pandemics. The current systems of incentives for drug development are… Continue Reading

EB 154: KEI statement on the Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

On Wednesday, 24 January 2024, Knowledge Ecology International (KEI) delivered the following statement on the Follow-up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. The innovation for… Continue Reading